Belgium’s Poison Control Centre reports a steep rise in overdoses involving Ozempic and Wegovy as their popularity for weight loss grows nationwide, prompting public health warnings
In a bold move to address a critical shortage of Novo Nordisk's diabetes drug Ozempic, Belgium has temporarily banned its use as a weight loss treatment
Recently, the initial global review of contemporary medicines for weight loss suggest that the use of this medicines cannot be justified based on current...
